On the main one hand, the benefits presented here could claim that treatment of p53 wild-type tumor cells with an HDAC inhibitor could weaken the antitumor aftereffect of Nutlin-3 and and used to acquire iPS cells induces p53 and p21 amounts
On the main one hand, the benefits presented here could claim that treatment of p53 wild-type tumor cells with an…